Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-116846
Filing Date
2024-10-24
Accepted
2024-10-24 07:00:10
Documents
29
Period of Report
2024-10-24

Document Format Files

Seq Description Document Type Size
1 6-K q32024_ir_presentation.htm 6-K 23458
2 EX-99.1 imab-ex99_1.htm EX-99.1 39940
3 GRAPHIC imab-ex99_1s1.jpg GRAPHIC 191359
4 GRAPHIC imab-ex99_1s2.jpg GRAPHIC 887835
5 GRAPHIC imab-ex99_1s3.jpg GRAPHIC 245643
6 GRAPHIC imab-ex99_1s4.jpg GRAPHIC 388211
7 GRAPHIC imab-ex99_1s5.jpg GRAPHIC 276768
8 GRAPHIC imab-ex99_1s6.jpg GRAPHIC 350443
9 GRAPHIC imab-ex99_1s7.jpg GRAPHIC 423474
10 GRAPHIC imab-ex99_1s8.jpg GRAPHIC 326931
11 GRAPHIC imab-ex99_1s9.jpg GRAPHIC 332242
12 GRAPHIC imab-ex99_1s10.jpg GRAPHIC 385640
13 GRAPHIC imab-ex99_1s11.jpg GRAPHIC 250824
14 GRAPHIC imab-ex99_1s12.jpg GRAPHIC 333704
15 GRAPHIC imab-ex99_1s13.jpg GRAPHIC 342801
16 GRAPHIC imab-ex99_1s14.jpg GRAPHIC 345375
17 GRAPHIC imab-ex99_1s15.jpg GRAPHIC 317883
18 GRAPHIC imab-ex99_1s16.jpg GRAPHIC 478375
19 GRAPHIC imab-ex99_1s17.jpg GRAPHIC 452523
20 GRAPHIC imab-ex99_1s18.jpg GRAPHIC 410622
21 GRAPHIC imab-ex99_1s19.jpg GRAPHIC 428641
22 GRAPHIC imab-ex99_1s20.jpg GRAPHIC 338497
23 GRAPHIC imab-ex99_1s21.jpg GRAPHIC 489108
24 GRAPHIC imab-ex99_1s22.jpg GRAPHIC 336587
25 GRAPHIC imab-ex99_1s23.jpg GRAPHIC 421703
26 GRAPHIC imab-ex99_1s24.jpg GRAPHIC 385212
27 GRAPHIC imab-ex99_1s25.jpg GRAPHIC 356794
28 GRAPHIC imab-ex99_1s26.jpg GRAPHIC 383002
29 GRAPHIC imab-ex99_1s27.jpg GRAPHIC 212517
  Complete submission text file 0000950170-24-116846.txt   13961057
Mailing Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850
Business Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850 (301) 670 2800
I-Mab (Filer) CIK: 0001778016 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39173 | Film No.: 241390674
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)